IMMUNO-ONCOLOGY INSIGHTS

On demand webinars

Rapid CAR-T cells: Accelerating manufacturing to enable fast transition of CAR-T cell therapies to the clinic

Rapid CAR-T cells: Accelerating manufacturing to enable fast transition of CAR-T cell therapies to the clinic

Tamara Laskowski, Kelly Purpura
7 December
Watch
Case study: becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand

Case study: becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand

Kitipong Uaesoontrachoon
28 November
Watch
The future of RNA-lipid nanoparticles for CAR-T cell therapy development

The future of RNA-lipid nanoparticles for CAR-T cell therapy development

Samuel Clarke
16 November
Watch
CAR-T: Why not me?

CAR-T: Why not me?

N Senutovitch, Y Guo, S Rafiq
9 November
Watch
Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing

Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing

Arina Riabinska
24 October
Watch
Enhancing non-viral genome editing and manufacturing of T and NK cells for immunotherapies

Enhancing non-viral genome editing and manufacturing of T and NK cells for immunotherapies

Ilgyun Im, Rebecca Lim
6 September
Watch
Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Sophia Lollies, Ian Johnston
31 August
Watch
Targeting EGFR to enhance NKT cell-mediated killing of lung cancer cells

Targeting EGFR to enhance NKT cell-mediated killing of lung cancer cells

T J Webb, D Ferrick, S Chvatal
27 July
Watch
Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle
26 July
Watch
Mononuclear phagocytes in tissue: from inflammation to cancer

Mononuclear phagocytes in tissue: from inflammation to cancer

Egle Kvedaraite
24 May
Watch
Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Stephan Wilmes
23 May
Watch
Cell profiling and biomarker discovery in a spatial context: a guide to analyzing your spatial biology data for immuno-oncology applications

Cell profiling and biomarker discovery in a spatial context: a guide to analyzing your spatial biology data for immuno-oncology applications

Telma Santos
17 May
Watch
Spatial biology out of the box: a pre-defined antibody panel for TME phenotyping of solid tumors

Spatial biology out of the box: a pre-defined antibody panel for TME phenotyping of solid tumors

Amy Jablonski
10 May
Watch
Spatial biology at its best – a complete workflow solution to advance immuno-oncology

Spatial biology at its best – a complete workflow solution to advance immuno-oncology

Jenia Schlegel, Sara Rahmati
3 May
Watch
Large-scale genome editing of primary human natural killer (NK) cells: A quest toward manufacture of clinically relevant CAR NK cells

Large-scale genome editing of primary human natural killer (NK) cells: A quest toward manufacture of clinically relevant CAR NK cells

Deepak Kumar
20 April
Watch
Next-generation CRISPR mRNA-LNPs and scale up manufacturing for CAR T cells

Next-generation CRISPR mRNA-LNPs and scale up manufacturing for CAR T cells

Reka Geczy, Bernice Thommandru
23 March
Watch
Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F Boj, Andrea Bisso
2 March
Watch
Assessing efficacy and MoA of mono and combo immunotherapies in preclinical humanized models

Assessing efficacy and MoA of mono and combo immunotherapies in preclinical humanized models

K Thiam PhD, E van der Horst PhD, A Surya PhD
18 January
Watch
The CAR toolkit: progress and challenges in CAR T/NK cell R&D and manufacture

The CAR toolkit: progress and challenges in CAR T/NK cell R&D and manufacture

H Dhamne, T Manning, S Steiner
7 December 2022
Watch
Modulation of both tumor and T cell apoptosis to enhance CART immunotherapy

Modulation of both tumor and T cell apoptosis to enhance CART immunotherapy

Marco Ruella
26 October 2022
Watch
Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

M Krainock, A Tan, J Simmons
19 October 2022
Watch
Manufacturing GMP-compliant iPSCs in closed and open systems

Manufacturing GMP-compliant iPSCs in closed and open systems

Dhruv Sareen, Chao Sheng
18 October 2022
Watch
Predicting patient response to immune targeted therapies via interrogation of the TME

Predicting patient response to immune targeted therapies via interrogation of the TME

Mark Uhlik PhD, Caroline Fong MD
12 October 2022
Watch
Feeder free expansion and closed wash and concentration of a clinically relevant number of human NK cells

Feeder free expansion and closed wash and concentration of a clinically relevant number of human NK cells

Erica Heipertz PhD
29 September 2022
Watch
Manufacturing of NK cells for the clinic: the Spanish experience

Manufacturing of NK cells for the clinic: the Spanish experience

A Pérez-Martínez PhD, M Giedlin PhD, M L Ammari PhD
27 September 2022
Watch
Accelerating immuno-oncology innovation using humanized mouse models

Accelerating immuno-oncology innovation using humanized mouse models

Santi Suryani Chen PhD
21 September 2022
Watch
Transient expression of mRNA lipid nanoparticle-based chimeric antigen receptors for safe immunotherapy

Transient expression of mRNA lipid nanoparticle-based chimeric antigen receptors for safe immunotherapy

Sandy Tretbar
6 July 2022
Watch
Thinking translational: Things to consider in CAR T cell research workflows

Thinking translational: Things to consider in CAR T cell research workflows

Saskia Rösch PhD
22 June 2022
Watch
Accelerating cell therapy discovery & development with non-viral gene engineering

Accelerating cell therapy discovery & development with non-viral gene engineering

D Hermanson, X Patrinostro, S Silaika
16 June 2022
Watch
Overcoming current challenges in immunotherapy drug development with patient-derived organoids

Overcoming current challenges in immunotherapy drug development with patient-derived organoids

Sylvia F Boj
15 June 2022
Watch
Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Chris Hughes
8 June 2022
Watch
Monitoring of circulating CAR T cells

Monitoring of circulating CAR T cells

A Graband, S Hünecke, M Bremm
31 May 2022
Watch
Enabling clinical grade manufacturing of gene-engineered NK cells

Enabling clinical grade manufacturing of gene-engineered NK cells

N Möker, E Ullrich MD, R Romee MD et al.
30 November 2021
Watch
Advancing engineered cell and gene therapy with precision gene editing

Advancing engineered cell and gene therapy with precision gene editing

Danilo Maddalo PhD, John Lambourne PhD
11 November 2021
Watch
Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis

Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis

C Souders PhD, T Dale PhD, N Bevan et al.
6 October 2021
Watch
The therapeutic gene editing solution – cell therapy for solid tumors

The therapeutic gene editing solution – cell therapy for solid tumors

B Sasu PhD, P Sivakumar PhD, J Trager PhD et al.
30 September 2021
Watch
Get your non-viral T cell engineering process ready for clinical manufacturing

Get your non-viral T cell engineering process ready for clinical manufacturing

M Rietenbach, S Wild, K Patel
21 September 2021
Watch
Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

N Senutovitch PhD, R Fan PhD, T J Laskowski PhD
5 August 2021
Watch
Accelerating CAR-T process development: The power of process insight

Accelerating CAR-T process development: The power of process insight

Julia Hupfeld PhD
29 July 2021
Watch
Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Y Ji PhD, S Ensari PhD, N Moore PhD
29 June 2021
Watch
Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

Laurens Sierkstra
10 June 2021
Watch
Protein biomarkers in plasma: revealing biological insights into the tumor microenvironment

Protein biomarkers in plasma: revealing biological insights into the tumor microenvironment

Genevieve Boland, Arnav Mehta
20 May 2021
Watch
Ultrahigh-content imaging helps to identify CAR target candidates against pancreatic adenocarcinoma

Ultrahigh-content imaging helps to identify CAR target candidates against pancreatic adenocarcinoma

Daniel Schäfer
20 April 2021
Watch
Navigating current translational challenges in establishing clinical CAR T cell therapy manufacture

Navigating current translational challenges in establishing clinical CAR T cell therapy manufacture

E García Guerreiro, S Kassim, M Dudley et al.
7 April 2021
Watch
Studying solid tumors and their micro-environment based on automated large-scale 3D fluorescence imaging

Studying solid tumors and their micro-environment based on automated large-scale 3D fluorescence imaging

Nizar Yousif, Hussein Hamzeh
25 March 2021
Watch
Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

S Pelletier PhD, F Eppler PhD, N Monhasery PhD
3 March 2021
Watch
Focus on allogeneic CAR-Ts manufacturing challenges and solutions

Focus on allogeneic CAR-Ts manufacturing challenges and solutions

M Langtry, A Sargent, B Ahmadian Baghbaderani
5 November 2020
Watch
Evolving the role of gene editing in cell therapy

Evolving the role of gene editing in cell therapy

J Frampton, T Thwaites, T Meissner
6 October 2020
Watch
The multi-modal manufacturing movement - you don't need to know the future to be ready for it

The multi-modal manufacturing movement - you don't need to know the future to be ready for it

Peter Walters, Noel Maestre PE LEED AP
30 September 2020
Watch
Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics

Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics

P Ott MD PhD, I Roodink PhD, N Senutovitch PhD
23 September 2020
Watch
Manufacturing of endogenous, non-engineered, antigen specific T cells against tumor targets

Manufacturing of endogenous, non-engineered, antigen specific T cells against tumor targets

Ali Mohamed, Megan Ciarlo
14 July 2020
Watch
Simplifying GMP CAR-T and CAR NK cell therapy manufacturing processes

Simplifying GMP CAR-T and CAR NK cell therapy manufacturing processes

M Elia Luevano Salinas PhD, X Wang PhD, S Fricke PhD et al.
9 June 2020
Watch
Gaining critical characterization insights for development of CAR-T therapies for solid tumors

Gaining critical characterization insights for development of CAR-T therapies for solid tumors

T Laskowski, J O’Rourke, J Krishnamurthy
16 May 2019
Watch